|
|
|
|
|
06.04.26 - 10:09
|
Corporate News: Kowa Company Ltd. (EQS)
|
|
|
K-679: Ein neuartiges, mit Antikörpern beladenes Unimicelle-Konjugat zeigt Tumor-selektive Pharmakokinetik, weitreichende intratumorale Verteilung und überlegene Wirksamkeit in nicht-klinischen Tiermodellen...
|
|
|
|
|
31.03.26 - 17:06
|
KKR and Taiyo Holdings Agree to Privatization to Accelerate Long-Term Growth (Business Wire)
|
|
|
KKR Tender Offer Receives Support from Taiyo Holdings' Board, Largest Shareholders and Founding FamilyTOKYO--(BUSINESS WIRE)--KKR, a leading global investment firm, and Taiyo Holdings Co., Ltd. (“Taiyo Holdings” or the “Company”; TSE stock code 4626), announced today that KJ005 Co., Ltd. (the “Offeror”), an entity owned by investment funds managed by KKR, intends to make a tender offer to acquire all the common shares of Taiyo Holdings (the “Tender Offer”). Taiyo Holdings' Board of Directors has resolved to support the Tender Offer. In addition, DIC Corporation (“DIC”), Taiyo Holdings' largest shareholder, Kowa Co., Ltd. (“Kowa”), an asset management company affiliated with Taiyo Holdings' founding family, and funds managed by Oasis Management Company Ltd. (“Oasis”) have each entered into agreements to participate in the Tender Offer or related transactions to privatize the Company. With these agreements in place, KKR has secured support for the transaction from the shareho...
|
|
|
23.02.26 - 09:51
|
XFRA: MWBMU - HANDELSUNTERBRECHUNG - TEIL 2 (XETRA)
|
|
|
AU000000GMD9
SG1M49904634
CA23344H1091
NZMLNE0001S0
KYG2S85A1045
AU0000066508
US58844R8842
KYG549581067
GB00BJL1ZF49
HK0000504214
GB00BPJHZ015
GB00BYYJL418
GB00BLH32M40
MHY622674098
JP3868500004
CA7469601032
GB00BN33TR63
AU0000119307
CA1358711010
KYG9898S1075
CA92834E3068
US69346N1072
SG1W55939399
KYG9898C1024
CA82938H1073
JP3601800000
SE0015949946
PLCLDTC00019
CA74739G1072
CNE1000076P8
US39813G1094
AU000000ALI3
JP3292900002
BMG2233G2014
PLGRMID00019
AU0000122251
GB00BMYX7295
BMG6682J1036
US6915436074
PLSTRWI00019
CA87402A1084
JP3759800000
KYG5340S1093
CA76611L2030
PLBKDGM00019
SE0010245373
HK0000544194
PLGNMTC00017
US4404071049
KYG6981F1090
AU0000079212
KYG2929M1087
SG1CI9000006
US29445S1006
KYG4066M1151
VGG0542G1028
SE0026820854
KYG009701064
US03464Y1082
US98955N2071
SG1EB6000000
US20451Q1040
NO0013711739
GB00BMDXQ672
US54572F1012
CA94357L1058
GB00BTXYPJ53
CNE1000040M1
CNE1000031F4
IT0005453003
SE0015988274
PLCRTCH00017
US09549B1044...
|
|
|
26.01.26 - 14:03
|
Arcutis Biotherapeutics, Inc. Announces Termination of Promotion Agreement with Kowa (GlobeNewswire EN)
|
|
|
WESTLAKE VILLAGE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that on January 23, 2026, the Company and Kowa Pharmaceuticals America, Inc. mutually agreed to terminate their promotion agreement. The agreement covered sales and promotion of ZORYVE® (roflumilast) by Kowa to primary care physicians and pediatricians in the United States....
|
|
|
26.08.25 - 23:36
|
XFRA: DIVIDEND/INTEREST INFORMATION - 28.08.2025 - JP3292900002 (XETRA)
|
|
|
Das Instrument 49N JP3292900002 KOWA COMPANY LIMITED EQUITY wird cum Dividende/Zinsen gehandelt am 27.08.2025 und ex Dividende/Zinsen am 28.08.2025
The instrument 49N JP3292900002 KOWA COMPANY LIMITED EQUITY has its pre-dividend/interest day on 27.08.2025 and its ex-dividend/interest day on 28.08.2025...
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
